NL7312350A - - Google Patents

Info

Publication number
NL7312350A
NL7312350A NL7312350A NL7312350A NL7312350A NL 7312350 A NL7312350 A NL 7312350A NL 7312350 A NL7312350 A NL 7312350A NL 7312350 A NL7312350 A NL 7312350A NL 7312350 A NL7312350 A NL 7312350A
Authority
NL
Netherlands
Application number
NL7312350A
Other versions
NL161152B (nl
NL161152C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7312350A publication Critical patent/NL7312350A/xx
Publication of NL161152B publication Critical patent/NL161152B/xx
Application granted granted Critical
Publication of NL161152C publication Critical patent/NL161152C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL7312350.A 1972-09-09 1973-09-07 Werkwijze voor de bereiding van een preparaat met bloeddruk verlagende werking en werkwijze voor de bereiding van de daarbij te gebruiken verbindingen. NL161152C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4199272A GB1383409A (en) 1972-09-09 1972-09-09 Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
NL7312350A true NL7312350A (cs) 1974-03-12
NL161152B NL161152B (nl) 1979-08-15
NL161152C NL161152C (nl) 1980-01-15

Family

ID=10422335

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7312350.A NL161152C (nl) 1972-09-09 1973-09-07 Werkwijze voor de bereiding van een preparaat met bloeddruk verlagende werking en werkwijze voor de bereiding van de daarbij te gebruiken verbindingen.

Country Status (17)

Country Link
US (1) US3960861A (cs)
JP (1) JPS4985078A (cs)
AR (1) AR203373A1 (cs)
AT (1) AT330785B (cs)
BE (1) BE804558A (cs)
CA (1) CA995673A (cs)
DE (2) DE2366106C2 (cs)
DK (1) DK131725C (cs)
ES (1) ES418612A1 (cs)
FR (1) FR2198751B1 (cs)
GB (1) GB1383409A (cs)
IE (1) IE38318B1 (cs)
IN (2) IN139088B (cs)
LU (1) LU68373A1 (cs)
NL (1) NL161152C (cs)
SU (1) SU555850A3 (cs)
ZA (1) ZA735660B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015018797A3 (en) * 2013-08-05 2015-04-16 Haplogen Gmbh Antiviral compounds

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044136A (en) * 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
GR79603B (cs) * 1982-07-24 1984-10-31 Pfizer
US4555569A (en) * 1983-06-28 1985-11-26 Ciba-Geigy Corporation Chromogenic quinazolines
CA2095213A1 (en) * 1990-11-06 1992-05-07 Jotham W. Coe Quinazoline derivatives for enhancing antitumor activity
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
DE4338396A1 (de) * 1993-11-10 1995-05-11 Basf Ag N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
IT1286302B1 (it) * 1996-04-10 1998-07-08 Rotta Research Lab Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso
IN188411B (cs) 1997-03-27 2002-09-21 Yuhan Corp
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6900220B2 (en) 2001-01-02 2005-05-31 Syntex (U.S.A.) Llc Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
AU2003281346B2 (en) * 2002-07-05 2007-04-05 F. Hoffmann-La Roche Ag Quinazoline derivatives
WO2008015270A1 (en) * 2006-08-04 2008-02-07 Merz Pharma Gmbh & Co. Kgaa Pyrazolopyrimidines, a process for their preparation and their use as medicine
US8871756B2 (en) * 2011-08-11 2014-10-28 Hoffmann-La Roche Inc. Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
AR099134A1 (es) * 2014-01-24 2016-06-29 Hoffmann La Roche Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina
JP6749343B2 (ja) 2015-05-20 2020-09-02 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 脊髄性筋萎縮症を処置するための化合物
JP6779972B2 (ja) 2015-07-16 2020-11-04 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 呼吸器合胞体ウイルス（ｒｓｖ）感染症の処置のためのｎ−［（３−アミノ−３−オキセタニル）メチル］−２−（２，３−ジヒドロ−１，１−ジオキシド−１，４−ベンゾチアゼピン−４（５ｈ）−イル）−６−メチル−４−キナゾリンアミンの結晶形
BR112018009281B1 (pt) 2015-11-12 2023-10-31 F. Hoffmann-La Roche Ag Composições para tratar atrofia muscular espinhal e seu uso
KR102488323B1 (ko) 2015-12-10 2023-01-12 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료 또는 개선을 위한 조성물
CN108137579B (zh) 2015-12-10 2022-01-07 豪夫迈·罗氏有限公司 桥连哌啶衍生物
FR3061494B1 (fr) 2016-12-29 2020-07-03 Arkema France Procede de synthese de dithiocarbamates cycliques fonctionnalises
BR112019025740A2 (pt) 2017-06-05 2020-06-23 Ptc Therapeutics, Inc. Compostos para tratar a doença de huntington
BR112019027717A2 (pt) 2017-06-28 2020-07-28 Ptc Therapeutics, Inc. métodos para tratar a doença de huntington
CA3067592A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. Methods for treating huntington's disease
KR20210005559A (ko) 2018-03-27 2021-01-14 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료 화합물
WO2020005882A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
EP3814345B8 (en) 2018-06-27 2024-10-30 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
EP4434990A1 (en) 2018-06-27 2024-09-25 PTC Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating huntington's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945859A (en) * 1960-07-19 Diaminoquinazolines and method of
BE501634A (cs) * 1950-03-02
US3155572A (en) * 1959-04-13 1964-11-03 Merck & Co Inc Compositions and methods for treating coccidiosis
GB1062357A (en) * 1965-03-23 1967-03-22 Pfizer & Co C Quinazolone derivatives
GB1131126A (en) * 1966-03-10 1968-10-23 Pfizer Ltd 2-vinyl-1,4-dihydroquinazoline derivatives
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3637701A (en) * 1969-03-03 1972-01-25 Sandoz Ag Certain nitrate derivatives of 4-aminoquinazolines
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015018797A3 (en) * 2013-08-05 2015-04-16 Haplogen Gmbh Antiviral compounds

Also Published As

Publication number Publication date
DE2345064C3 (de) 1979-10-25
AR203373A1 (es) 1975-09-08
FR2198751B1 (cs) 1977-01-28
DE2366106C2 (de) 1980-02-14
DE2345064B2 (de) 1979-03-08
IN141109B (cs) 1977-01-22
FR2198751A1 (cs) 1974-04-05
ATA774573A (de) 1975-10-15
LU68373A1 (cs) 1975-05-21
DE2366106B1 (de) 1979-06-21
AU5960673A (en) 1975-02-27
DK131725B (da) 1975-08-25
AT330785B (de) 1976-07-26
NL161152B (nl) 1979-08-15
DE2345064A1 (de) 1974-04-11
CA995673A (en) 1976-08-24
IN139088B (cs) 1976-05-08
IE38318L (en) 1974-03-09
BE804558A (fr) 1974-03-06
ES418612A1 (es) 1976-07-16
SU555850A3 (ru) 1977-04-25
US3960861A (en) 1976-06-01
IE38318B1 (en) 1978-02-15
DK131725C (da) 1976-01-26
ZA735660B (en) 1974-07-31
NL161152C (nl) 1980-01-15
GB1383409A (en) 1974-02-12
JPS4985078A (cs) 1974-08-15

Similar Documents

Publication Publication Date Title
IN141109B (cs)
CS158596B2 (cs)
CS152248B1 (cs)
CS153164B1 (cs)
CS154512B1 (cs)
CS154536B1 (cs)
CS156355B1 (cs)
CS161280B1 (cs)
CS159557B1 (cs)
CS159520B1 (cs)
CS156877B1 (cs)
CH578748A5 (cs)
CH583223A5 (cs)
CH565606A5 (cs)
CH566594A5 (cs)
CH567798A5 (cs)
CH567840A5 (cs)
CH568007A5 (cs)
CH569578A5 (cs)
CH573048A5 (cs)
CH575247A5 (cs)
CH575525A5 (cs)
CH577227A5 (cs)
CH577869A5 (cs)
CH563909A5 (cs)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: PFIZER